📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
5 articles
AVG GRADE
HIGH
score: 0.80
SENTIMENT
BULLISH
TOTAL VIEWS
48
INDV Latest News & AI Sentiment Analysis
5 articles · Grade: HIGH · Real-time AI-graded coverage
RECENT COVERAGE · 6 ARTICLES
Supernus, Indivior stock jumps after all-stock deal to merge
SUPN and INDV announced an all-stock merger, triggering immediate positive price action in both equities. All-stock deals typically...
Supernus Announces Second Quarter 2026 Financial Results
Supernus Pharmaceuticals delivered a 32% revenue beat in Q2 2026, with core growth products surging 52% year-over-year to $175.7M. This...
Indivior Reports Second Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance
Indivior delivered Q2 2026 results showing 14% year-over-year revenue growth to $343 million, signaling sustained commercial momentum in...
Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale
Supernus Pharmaceuticals (SUPN) and Indivior announced a merger creating a combined CNS biopharmaceutical entity with approximately $2.2...
Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale
The all-stock merger between Supernus Pharmaceuticals (SUPN) and Indivior Pharmaceuticals (INDV) represents a significant consolidation...
5 Biotech Stocks That Skyrocketed 105% To 235% — TWST, INDV, MIRM & More
This article highlights a curated selection of biotech equities that have delivered substantial gains, ranging from 105% to 235%,...
RELATED TICKERS
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice